# Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/specific-tp53-subtype-as-biomarker-for-immune-checkpoint-inhibitors-in-lung/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hao Sun,Si‐Yang Maggie Liu,Jiaying Zhou,Jintian Xu,Huang-Kai Zhang,Hong‐Hong Yan,Jiaojiao Huan,Pingping Dai,Chong‐Rui Xu,Jian Su,Yanfang Guan,Xin Yi,Rongshan Yu,Wen‐Zhao Zhong,Yi‐Long Wu |
| Citations | 255 |
| DOI | 10.1016/j.ebiom.2020.102990 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1016/j.ebiom.2020.102990 |
| OpenAlex ID | https://openalex.org/W3084896449 |
| PMID | 32927274 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Hong‐Hong Yan](https://scholariq.org/researchers/hong-hong-yan/)
- [Chong‐Rui Xu](https://scholariq.org/researchers/chong-rui-xu/)
- [Wen‐Zhao Zhong](https://scholariq.org/researchers/wen-zhao-zhong/)

## Paper journal

- [EBioMedicine](https://scholariq.org/journals/ebiomedicine/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.